Cimiracemoside C is a triterpene glycoside isolated from Cimicifuga racemosa (black cohosh). It is primarily used in biochemical and pharmacological research to investigate its biological activities, including antioxidant and anti-inflammatory effects. Studies have demonstrated its potential in modulating cellular signaling pathways related to apoptosis and cell proliferation. It shows promise for development into active pharmaceutical ingredients targeting oxidative stress-associated chronic conditions, such as diabetes, cardiovascular diseases, and neurodegenerative disorders. While black cohosh extracts are explored in dermatological and cosmetic applications, specific research on Cimiracemoside C focuses more on its broader therapeutic potentials rather than topical skin benefits.